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ABSTRACT 
 
Introduction: Indians belong to high-risk group, universal screening policy is applicable to Indian population. 
There is a two way approach for screening - one step and two-step. The two-step approach is cumbersome and 
inconvenient for the patients. Aims: To study the prevalence of gestational diabetes mellitus using 50gm 1 hour oral 
glucose challenge test (OGCT). To assess the need for universal screening and to compare the occurrence of GDM 
in normal antenatal cases with those patients who have risk factors for GDM. Material and Methods: This was a 
prospective study done over a period of one and half years. The study included 600 pregnant women of 24-32weeks 
gestation who underwent the 1 hour OGCT with 50 gm glucose followed by 75gms OGTT in positive individuals. 
Results: The mean age of study population was 22.99 years. Parity wise, 52.33 % were primigravida. The mean age 
of GDM patients was 26.1 Years.  19.6 of study population had risk factors for GDM. Past history of fetal loss 
beyond 20 weeks of gestation, age above 25yrs, family history of type 2 DM were the three most common risk 
factors being present in 17%, 1.66% and 1.66% cases. Positivity was more common in patients with risk factors for 
GDM compared to those without risk factors. Overall prevalence of GDM by the two step approach was 7% in our 
study population.  Among 42 GDM patients 31 patients had one or more risk factors. Family history   of diabetes 
(14.28%) and previous history of fetal loss (14.28%) were the two most prevalent risk factors.  Only 35.7 % of 
GDM patients were >25yrs. Conclusions: For universal screening, we suggest 50gms OGCT which has 100% 
sensitivity, and 98.75 % specificity as observed in our study. This procedure is easily acceptable, economical, and 
feasible in the Indian context.   
  
Key words: Oral glucose challenge test, Gestational diabetes, Antenatal. 
Introduction 
Gestational diabetes mellitus (GDM) is defined as any 
degree of glucose intolerance recognized for the first 
time during pregnancy.[1]GDM complicates 
approximately 4% of pregnancies. Women with GDM 
have approximately 50% risk of developing type 2 
Diabetes over the next 10 years. [2]Pregnancy offers a 
unique opportunity to diagnose or possibly prevent 
diabetes among women at risk to develop type 2  
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diabetes in later life. The prevalence of GDM ranges 
from 1-14% of pregnancies depending on the ethnic or 
racial composition of the population studied and on the 
diagnostic criteria used.[3] GDM represents nearly 
90% of all pregnancies complicated by diabetes. 
[2]The prevalence of GDM is increasing globally but 
there is lack of uniformity in screening policy to be 
used i.e., universal or selective, as well as the 
diagnostic criteria to be used. [1] The fourth 
international workshop-conference on GDM 
recommends universal screening for women in ethnic 
groups with high rates of carbohydrate intolerance 
during pregnancy and diabetes later in life and 
selective policy for women at low risk.[4]Since, 
Indians belong to high-risk group (11 fold increased 
risk when compared to white Caucasian women), 
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universal policy is applicable to Indian population.[5] 
There is a two way approach for screening-one step 
and two-step. The two-step approach is cumbersome as 
it involves an initial glucose challenge test (OGCT) 
followed by a diagnostic oral glucose tolerance test 
(OGTT). The one-step approach is easier as it serves 
dual purpose of screening and diagnosing with a single 
test. In either of the approaches, the final diagnosis 
should be based on OGTT.[4]At present, GDM is 
regarded as a proven disease entity. There is 
controversy regarding the screening and diagnostic 
methods to be used, about ideal cut off blood glucose 
levels, and the treatment aspects.[6]Indian population 
falls under moderate to high risk group for GDM.  In 
recent years there has been an increasing trend towards 
diabetes in India. Contributing factors could be 
sedentary life style, urbanization, and intake of a more 
westernised diet. With adoption of western life style, 
incidence of type 2 DM is on the rise in Indian 
population and also in the number of women with 
GDM is increasing.[7]Among south Asian countries, 
Indian women have the highest frequency of 
GDM.[8]Hence, this study was undertaken to look at 
the prevalence and risk factors of GDM in the local 
population. Universal screening during pregnancy has 
become important in our country. For this, we need a 
simple procedure that is easily acceptable, economical 
and feasible. Hence, in this study the easier one-step 
procedure to screen and diagnose GDM was used to 
see if it can be as effective as the cumbersome two-step 
method in detecting GDM. 
 
Aims and Objectives 
 
To study the prevalence of gestational diabetes mellitus 
using 50gm 1 hour OGCT. To assess the need for 
universal screening and to evaluate and compare the 
occurrence of GDM in normal antenatal cases with 
those patients who haverisk factors for GDM. 
 
Material and Methods 
 
This was a prospective clinical study carried out over a 
period of one and half years. The study included 600 
randomly selected pregnant women of 24-32weeks 
gestation. The study group comprised of both  out-door 
and indoor patients from department of Obstetrics and 
Gynecology, C.K.M. Government Maternity Hospital, 
Warangal.All pregnant women with singleton or 
multiple pregnancies between 24-32 weeks of gestation 
irrespective of presence or absence of risk factors for 
GDM were included. Individuals who had history of 
pre-gestational diabetes (Overt diabetes), history of  
intake of drugs  that   affect   glucose metabolism like 
corticosteroids and patients who refused to undergo 
screening and diagnostic test for GDM were excluded 
from the study. 
 
Procedure of the study 
 
All pregnant women fulfilling the inclusion criteria 
underwent detailed clinical evaluation including 
detailed history taking and clinical examination. All the 
subjects were screened for GDM by 50gm, 1 hour oral 
glucose challenge test (OGCT). If 1 hour post-prandial 
glucose, PPG> 140 mg/dl, patient was tested by two 
step method i.e. with 75gms OGTT and individuals 
with venous blood levels more than 180 mg% were 
labelled as having GDM. 
 
Method of performing 50 gm OGCT 
 
Fasting was not a prerequisite.50gm of glucose was 
dissolved in 200ml of water and the patient was asked 
to drink it within 5 min. The time was noted. Venous 
blood was drawn after 1 hour. If the value 
was>140mg/dl, the patient underwent OGTT with 
75gms glucose. The occurrence of GDM in the study 
population was evaluated. 
 
Results 
 
Among the 600 patients none had adverse effects of 
nausea and/or vomiting. All patients accepted the test 
readily.The prevalence of GDM in the study population 
was evaluated. Clinical profiles of the study group 
were categorized into two groups as with and without 
risk factors for GDM.According to parity, 314 
(52.33%) were primigravida and hence these 
individuals could not be evaluated for risk factors in 
previous pregnancy and 286 (47.66%) were 
multigravida. 
  
Table 1: Age distribution of study population 
 
Age in years 
 
No ( % ) 
 < 20  38 (6.33%) 
 > 20 < 25  
 
466 (77.66%) 
 > 25 < 30 83(13.83%) 
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> 30 < 35  
 
17 (2.83%) 
 > 35  2(0.33%)  
 Total 
 
600 
 As per demographic characteristics, the mean age of patients was 22.99 years. 
Table 2: Prevalence of various risk factors 
 
Risk Factor 
 
No (%) 
 
Age > 25 years 
 
102 (17%) 
 Family history of DM 
 
10(1.6%) 
 Obesity(BMI> 27.5Kg/m2)  
 
11(1.83%) 
 Past history of macrosomia 
 
- 
 Past history of GDM 
 
1 (0.16%) 
 Past history of fetal loss 
 
10(1.6%) 
 
Past history of congenital anomalies 
 
3 (0.5%) 
 Past history of premature baby 
 
5 (0.8%) 
 Unexplained neonatal loss 
 
- 
 Any of the above 
 
118(19.6%) 
 
No risk factors 482 (80.3 %) 
 
The study population showed one or more than one risk factor for GDM in 118 (19.6%) cases. 
 
Table 3 Risk Factors in GDM cases which were OGTT Positive 
 
Risk Factor 
 
No of cases 
 
Percentage 
 
Age > 25 years 
 
15 
 
35.7% 
 Family history of DM 
 
6 
 
14.28% 
 Obesity(BMI> 27.5Kg/m
2
) 
 
5 
 
11.9% 
 Past history of macrosomia 
 
- 
 
- 
 Past history of GDM 
 
1 
 
2.3% 
 Past history of fetal loss 
 
6 
 
14.2% 
 Past history of congenital anomalies 
 
2 
 
4.7% 
 Past history of premature baby 
 
4 
 
9.5% 
 Unexplained neonatal loss 
 
- 
 
- 
 No risk factor 11 26.19% 
 
Among 42 GDM patients 31 (73.8 %) had one or more 
risk factors for GDM and 11 (26.19 %) of these had no 
risk factor. Family history of diabetes mellitus, obesity 
and previous history of fetal loss were the most 
common risk factors. The mean age of GDM patients 
was 26.1 years. Age distribution of the 42 GDM 
patients showed 27 (64.2 %) individuals less than 25 
years. Only 15 (35.7%) were > 25years i.e, in the risk 
age group. Complications such as pregnancy induced 
hypertension and polyhydramnios were seen in 10 
(23.80 %) and 4 (9.52 %) cases respectively. Dietary 
management alone was done for 15 (35.71 %) cases, 
whereas, 27 (64.28 %) cases were put on insulin 
treatment along with dietary modification. All these 
patients were under the care of endocrinologist. Insulin 
doses were fixed and titrated according to the 
endocrinologist’s advice. 
Results of 50 gm OGCT: 
Among 600 study population, 49 patients (8.13 %) 
were diagnosed as positive i.e., GDM, according to 
WHO criteria of 1 hour 50 g OGCT value being > 
140mg/dl. All 49 patients underwent OGTT with 75 
gm glucose as per the two step method for diagnosing 
GDM. Individuals having blood glucose > 180 mg% 
were taken as definitely positive for GDM. By two –
step method, 42 (7 %) patients were detected to have 
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GDM. There were 7 cases (14.28%) which had positive 
OGCT but negative OGTT. 
 
Discussion 
 
The discussion is based on observations and results of 
our study as compared to those obtained from the 
literature. A 1989 review of published controlled trials 
of gestational diabetes by Hunter et al [9] reported that 
the glucose tolerance test is poorly reproducible, that 
the perinatal complications associated with gestational 
diabetes have been given undue importance. The report 
also states that there is no population benefit as such 
which can be attributed to the screening, diagnosis, and 
treatment of GDM. The report had called for cessation 
of all forms of glucose tolerance testing. Contrary to 
this report, a 1996 survey by the American College of 
Obstetricians and Gynaecologists (ACOG) reported a 
favourable outcome by performing a 50 gm 1-hour 
screening test for GDM on their patients. [3]Long back 
in 1960 itself, O’Sullivan et al noted that women with 
undetected gestational diabetes were more likely to 
have stillbirths. [10]Pettitt et al. demonstrated a direct 
relationship between the plasma glucose level at 2 
hours after a 75-gm glucose load and the perinatal 
mortality rate in a cohort of Pima Indian women 
,though the results were not used in management.[11] 
Although both these studies are not perfect, and may 
have been affected bya number of factors, they still 
suggest that one should go ahead with the testing for 
GDM so as to reduce the perinatal mortality and 
complications. Clinical recognition of GDM is 
important because the therapy, dietary modifications, 
necessity of insulin and antepartum fetal surveillance 
can reduce the well described GDM associated 
perinatal morbidity and mortality. The frequency of 
GDM is highly variable and generally reflects the 
underlying pattern of type 2 diabetes in a particular 
population. Prevalence of GDM reported in different 
studies is 4 % [12]to as high as 13.9 %in a study by 
Rajput et al. [13] which compares well with the present 
study of 7 %.Coming to the presence of risk factors, 
prevalence of GDM in a study population will depend 
on various risk factors and degree of correlation of risk 
factors with GDM. We included the risk factors as 
recommended by the fourth international workshop 
conference on GDM with some modifications. As it 
was not possible to know the weight before pregnancy, 
we used the criteria of BMI >27.5kg/m2 during 
pregnancy. As for the demographic characteristics, a 
number of investigators[14] have found that maternal 
age is highly correlated with the risk of GDM. It is 
expected that prevalence of GDM in a population will 
depend on the age distribution of the population 
studied. In our study, out of 600 subjects, 102 (17 %) 
cases were above 25years. In the study by Bhattacharya 
et al,[15] the number of patients in the risk age group 
was 33.75 % and prevalence of GDM was 3 %. Jindal 
et al [16] have taken > 30 years as a criterion for risk 
factor and found a high prevalence of 9 % of GDM. In 
western studies majority of population falls in the risk 
age group. In a study by Dixon et al,[17]82.2 % 
subjects were more than 25 years age. In western 
studies a higher prevalence of GDM is expected. 
However, most of the studies have shown a prevalence 
rate of 3-5%. This may be because of ethnic variation. 
Out of 600 of our study population 19.6 % had one or 
more risk factors for GDM. This is very low as 
compared to the western studies because pregnancy is 
usually delayed in western countries and most of the 
pregnant women fall in the risk age group. Dixon et 
al[17] reported a very high percent 90.1 % of his 
subjects as having one or more risk factors. 
Bhattacharya et al[15] found 25 % and Jindal et al 
[16]reported 43.66 % of his subjects to have one or 
more risk factors. Migrant Indian communities in other 
parts of the world show very high prevalence of GDM. 
This can again be due to the fact that migrant Indians 
have pregnancy at a later age. Past history of fetal loss 
was present in 0.5 % and 14.66 % of the study groups 
as reported by Dixon et al [17]and Jindal et al[16] 
respectively. In the present study it was 1.66 %. It is 
the most common risk factor in Indian studies, 
including ours. However, this is unlikely to be a 
reflection of high prevalence of GDM in our 
population because there are multiple other causes 
responsible for fetal loss that are more common in our 
population. Another difference in comparison to 
western studies was low prevalence of obesity in our 
study population, which was 1.83 %, whereas, Dixon et 
al [17] found 47 % of their study group to be obese. 
Jindal et al [16] had 33.3 % subjects who were obese. 
This is likely due to the regional difference in different 
populations. 
 
Table 4: Prevalence of risk factors in GDM patients in various studies 
 
Risk factors 
 
Dixon et al(%) Bhattacharya et al (%) 
 
 
 
 
Jindal et al(%) Present study (%) 
Age >25 years 
 
90.4 
 
66.66 44.11 
 
17.00 
 Family h/o DM 
 
22.7 
 
33.33 
 
22.22 
 
1.60 
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Obesity 
 
47 
 
NA 
 
33.3 
 
1.83% 
 Past h/o macrosomia 
 
29.2 
 
0 
 
29.6 
 
0 
 Past h/o GDM 
 
19.4 
 
NE 
 
22.2 
 
0.16% 
 Past h/o fetal loss 
 
2.7 
 
8.33 
 
44.4 
 
1.66% 
 Past h/o prematurity 
 
NE 
 
NA 
 
NE 
 
0.83% 
 Total 
 
97 
 
66.66 
 
88.9 
 
19.66 
 
 
We found that family history of diabetes, past history 
of fetal loss and congenital abnormalities were 
statistically more common in GDM population as 
compared to normal population. Similar findings have 
been reported by other authors. All studies have shown 
significantly higher proportion of GDM patients in the 
high risk age group. These findings were not 
reproduced in our study; however, the mean age of 
GDM population was significantly higher as compared 
to normal population in our study also.The GDM 
patients had more complications of pregnancy induced 
hypertension (PIH) and polyhydramnios.In our study, 
we encountered 10 (23.8 %) cases and 4 (9.52 %) cases 
respectively. Such complications can lead to significant 
perinatal mortality and morbidity. 
 
Table 5: Screening test results for OGTT 
 
 
 
GDM Diseased 
 
Non GDM 
Positive Test 
 
42 (a) 
 
7(b) 
 Negative Test 
 
0(c) 
 
551 (d) 
 
 
Sensitivity =    (a/a+c) x 100=100% 
Specificity= (a/b+d) x 100= 98.75 % 
 
When compared to Ramachandran et al's[18]study, 
prevalence of GDM in the present study is high. The 
high prevalence was partly due to different diagnostic 
criteria i.e., WHO criteria [19] and may partly be due 
to original increasing trend in the prevalence of GDM. 
There is a wide variation in the prevalence of GDM in 
different populations. A large multi-ethnic study in 
London by Dornhost et al [20] showed a high incidence 
of GDM in non-white women, with a relative risk of 
3.1 % for blacks, 7.6 % for south Caucasians, and 11.3 
% for Indian population. 
The lower prevalence of GDM in our study population 
was partly due to lower mean age of pregnant women; 
compared to age of Asian women studied in the U.K. 
The other possible reasons are lower proportion 
(23.36%) of study population with risk factors. 
Evidence, that treatment, significantly reduces the 
perinatal morbidity and mortality support for a 
universal screening program. Screening for GDM and 
appropriate treatment reduce the maternal and fetal 
morbidity. Introduction of post- partum life style 
modification and patient education reduce the 
incidence of Type 2 DM in later life.  
Universal screening during pregnancy has become very 
important. The two step procedure of screening with 50 
gm OGCT and then diagnosing GDM based on the cut 
off values with 75 gm OGTT is not practical as the 
pregnant women have to visit the clinic at least twice 
and the number of blood samples drawn varies from 3 
to 5 which cause lot of inconvenience to the patients. 
For universal screening, we suggest 50gmsOGCT as it 
is 100% sensitive, and 98.75 % specific as per the 
observation of our study. As this is a one-step 
procedure, it is easily acceptable, economical, feasible 
and applicable to the Indian context. 
 
Conclusion 
 
In the Indian context, screening is essential in all 
pregnant women. Indian women have an eleven fold 
increased risk of developing glucose intolerance during 
pregnancy compared to Caucasian women. GDM can 
be present in patients who do not have any risk factors. 
Hence, universal screening during pregnancy has 
become important. The two step procedure of 
screening with 50gmsOGCT and then diagnosing 
GDM based on the cut off values with 75 gms OGTT is 
not practical as the pregnant women have to visit the 
clinic at least twice and the number of blood samples 
drawn vary from 3 - 5 which women resent. For 
universal screening, we suggest 50gms OGCT which 
has 100% sensitivity, and 98.75 % specificity as 
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observed in our study. This procedure is easily 
acceptable, economical, and feasible in the Indian 
context. 
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